Arcus Biosciences (RCUS)
(Delayed Data from NYSE)
$17.39 USD
+0.42 (2.48%)
Updated Sep 12, 2024 04:00 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Brokerage Reports
Arcus Biosciences, Inc. [RCUS]
Reports for Purchase
Showing records 1 - 20 ( 127 total )
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology- ESMO 2024 Abstract Titles for Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Q2 Financials; ccRCC Data in Q4:24 Set to Support Large Opportunity for Cas
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Going With the Gut: EDGE-Gastric and ARC-9 at ASCO
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
1Q:24 Financials; Late-Stage Dev Continuing for HIF-2a, TIGIT, Adenosine
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Q4/FY23 Financials; Cas Initial Topline Efficacy; STAR-131 in Periop NSCLC
Provider: Wedbush Securities Inc.
Analyst: ERT V
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Quemli High mOS in mPDAC; Tira in EC Supports Dom in GI
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
RCUS, EXEL to Initiate Ph1b/2 STELLAR-009 of Zanza+AB521 in Solid Tumors, ccRCC
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R